National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Prevention and Cessation of Cigarette Smoking: Control of Tobacco Use (PDQ®)
Patient VersionHealth Professional VersionLast Modified: 05/01/2008
Table 1. Nicotine Patches

  Brand  Dose   Side Effects   Comments 
d = day; OTC = over the counter; Rx = prescription; wk = week.
Rx Habitrol 7–21 mg/d Erythema Use for 6–12 wk
OTC Nicoderm CQ 7–21 mg/d Pruritus Use for 6–12 wk
OTC Nicotrol 5–15 mg/d Burning at site Use for 14–20 wk
Rx ProStep 11–22 mg/d Local irritation Use for 6–12 wk


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov